Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1999
11/10/1999CN1234801A 3-methylamide derivatives of 5H-pyrrolo [2,1,-C] [1,4]-benzodiazepines
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234737A Pharmaceutical compositions containing S-alkylisothiouronium derivatives
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234272A Medicine for treatment of piles and preparation method thereof
11/10/1999CN1046277C Quinoline derivative, preparing method and use thereof
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981776 Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981701 Tumor necrosis factor inhibitory protein and its purification
11/09/1999US5981599 Inorganic ion receptor active compounds
11/09/1999US5981583 For use in the treatment of pathological conditions such as toxic shock, acute inflammatory conditions, acute phase response, atherosclerosis and cancer
11/09/1999US5981568 Therapeutic inhibitor of vascular smooth muscle cells
11/09/1999US5981559 Azole derivative with leukotriene (LTs) antagonizing activity and thromboxane (TX) A2 antagonizing activity
11/09/1999US5981556 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
11/09/1999US5981553 Heterocycle substituted propenoic acid derivatives as NMDA antagonist
11/09/1999US5981544 For treatment of diseases involving an alteration in the venous function and/or inflammatory edema
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981535 Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
11/09/1999US5981531 For inhibiting platelet aggregation
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981512 Means for treating radiation injuries
11/09/1999US5981511 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
11/09/1999US5981498 Agent for improving the blood circulation
11/09/1999US5981495 Benzopyran derivative and method for treating heart disease using this derivative
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981487 Method of inhibiting smooth muscle cell proliferation
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981252 Enzyme for diagnosis of atherosclerosis; for screening enzyme inhibitors as therapy
11/09/1999US5980946 Collagen formulations
11/09/1999US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/09/1999CA2177780C New arylalkyl(thio)carboxamide compounds, their preparation processes and the pharmaceutical compositions that contain them
11/09/1999CA2008126C Low dose benazepril/thiazide diuretic composition
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055867A1 Delayed rectifier potassium channel subunit
11/04/1999WO1999055865A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999WO1999055859A2 Cd40-interacting and traf-interacting proteins
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055725A1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
11/04/1999WO1999055708A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
11/04/1999WO1999055701A1 Process for making 1,3-disubstituted-4-oxocyclic ureas
11/04/1999WO1999055700A1 Process for making 1,3-disubstituted-4-oxocyclic ureas
11/04/1999WO1999055690A1 Guanidine derivatives
11/04/1999WO1999055681A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
11/04/1999WO1999055680A1 Aryl fused azapolycyclic compounds
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055667A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
11/04/1999WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999WO1999055382A1 Adenoviral vector encoding anti-apoptotic bcl-2 gene and uses thereof
11/04/1999WO1999055349A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999WO1999055343A1 Cnre binding factors and uses thereof
11/04/1999WO1999055337A1 Stabile compositions comprising levosimendan and alginic acid
11/04/1999WO1999055335A1 Substituted tricyclic pyrazole derivatives with protein kinase activity
11/04/1999WO1999055328A1 Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose
11/04/1999WO1999055327A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate
11/04/1999WO1999055315A1 Periadventitial delivery device
11/04/1999WO1999055313A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999055305A2 Controlled release peroral compositions of levosimendan
11/04/1999DE19819548A1 Biphenylderivate Biphenyl
11/04/1999DE19819023A1 Thienopyrimidine Thienopyrimidines
11/04/1999DE19812204A1 Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung The use of extracts from Cimicifuga racemosa and Belamcanda sinensis estrogenartiges organ-selective drugs without a uterotrophic effect
11/04/1999CA2330934A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate
11/04/1999CA2330685A1 Process for making 1,3-disubstituted-4-oxocyclic ureas
11/04/1999CA2330576A1 Substituted benzazocines as nicotine-binding inhibitors
11/04/1999CA2329864A1 Fire-resistant non-explosive solid mixtures containing nitroglycerine and water-free lactose
11/04/1999CA2329301A1 Substance mixture for topical application comprising olive oil and honey
11/04/1999CA2328970A1 Pellets having a core coated with a lipid lowering agent and a polymer
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2326114A1 Periadventitial delivery device
11/04/1999CA2325736A1 Guanidine derivatives
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953350A1 Extended release formulation of diltiazem hydrochloride
11/03/1999EP0953349A1 Compositions comprising nitroglycerin and anhydrous lactose
11/03/1999EP0952975A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
11/03/1999EP0952974A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/03/1999EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999EP0952835A1 Method of treatment of heart disease caused by chlamydia pneumoniae
11/03/1999EP0952830A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/03/1999CN1234037A Subsd. aminoalkane phosphonic acids
11/03/1999CN1234032A Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines contg. same as active ingredient
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1233498A Ingredients for food beneficial for coronary heart disease patient and tumor patient
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/03/1999CN1233418A Health-care food for invigorating brain and anti tiredness
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977179 Nitro-benzamides useful as anti-arrhythmic agents
11/02/1999US5977177 Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
11/02/1999US5977163 Water soluble paclitaxel prodrugs
11/02/1999US5977157 Methods for inhibiting endometriosis
11/02/1999US5977155 Cardiovascular, kidneys
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977144 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
1 ... 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 ... 1595